Both in Pharmaceuticals
Aurinia Pharmaceuticals vs Biohaven
Over the past year AUPH returned +19.9% and BHVN returned +9.2%; their daily moves had a correlation of 0.21.
AUPH +19.9% BHVN +9.2%Growth of $1, one year, split-adjusted
| Metric | AUPH | BHVN |
|---|---|---|
| Price | $17.11 | $15.24 |
| Market cap | $2.29B | $2.30B |
| Today | +3.32% | −2.37% |
| 1 month | +9.1% | +26.2% |
| 6 months | +5.3% | +51.8% |
| Year to date | +7.3% | +35.0% |
| 1 year | +29.9% | +2.6% |
| Revenue growth (YoY) | +13.9% | — |
| Gross margin | 90.1% | — |
| Net margin | 37.9% | — |
| P/E (TTM) | 7.3× | — |
| Price / sales | 7.1× | — |
| Net cash | $431.7M | -$103.2M |
| Dividend yield | — | — |
| Volatility (60d) | 31.0% | 91.2% |
| Short % of float | 7.3% | 14.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).